It has been shown that G-CSF or Peg-G-CSF significantly attenuate not only the period of neutropenia and/or aplasia in victims suffered radiation but also strengthen recovery of neutrophil counts post anti-cancer therapy (Berger et al., 2006). The gene discussed is CSF3; the disease is cancer.